Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Canopy Growth Corp

(TSX: WEED.TO)
Add to Portfolio
-0.67 (-3.20%)
as of Nov 15, 2019

Last 20.29
Change -0.67 (-3.20%)
Open 20.08
Prev. Close 20.96
Today's Range
20.08
20.99
52wk Range
20.08
70.98
Volume 2,077,386
Avg Volume 1,612,016

Perfomance Comparison

Name Today 3-Month 1-Year
WEED.TO -3.20% -41.99% -56.35%
$TXCX +0.33% +2.74% +12.36%
$TXSC -0.03% +3.51% +11.98%
DJIA +0.80% +4.51% +10.74%
S&P 500 +0.77% +4.76% +14.05%

Key Statistics

Annual EPS -5.87
Dividend Yield N/A
P/E Ratio N/A
Market Capitalization, $K 7,291,265
Weighted Alpha -65.80
Standard Deviation -0.68
Profit Margin -6.49%
Beta 5.35

Growth Rates

YTD -44.63%
1-Year -54.75%
3-Year +66.35%

Opinion

Sell Hold Buy

Recent Headlines

Most actively traded companies on the TSX

CP - Thu Nov 14, 04:46PM EST
TORONTO — Some of the most active companies traded Thursday on the Toronto Stock Exchange:(full story)
ACB.TO: 3.59 (-0.79), MFC.TO: 26.31 (+0.05), WEED.TO: 20.29 (-0.67), TGOD.TO: 0.70 (-0.13), ECA.TO: 5.76 (+0.01), ENB.TO: 50.51 (+0.51), CGX.TO: 24.21 (-0.11)

Canopy Growth reports $374.6M Q2 loss, restructures

CP - Thu Nov 14, 07:11AM EST
SMITH FALLS, Ont. — Canopy Growth Corp. reported a $374.6-million loss in its latest quarter as the company restructured its portfolio of cannabis softgels and oils.(full story)
WEED.TO: 20.29 (-0.67)

Canopy Growth Reports Second Quarter Fiscal 2020

PR Newswire via COMTEX - Thu Nov 14, 06:30AM EST
Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NYSE: CGC) today announced its financial results for the second quarter ended September 30, 2019. All financial information in this press release is reporte(full story)
WEED.TO: 20.29 (-0.67), CGC: 15.33 (-0.51)

Regulators Take Further Steps to Expand the Medical

PR Newswire via COMTEX - Wed Nov 13, 09:00AM EST
The medical cannabis industry continued to progress after the National Health Services in England and Wales recently decided to approve cannabis-based medicines. Specifically, three treatments using medicinal cannabis were approve(full story)
CRFTF: 0.1325 (-0.0016), CGC: 15.33 (-0.51), WEED.TO: 20.29 (-0.67), CRON: 6.28 (-0.54), CRON.TO: 8.36 (-0.67)

Psilocybin Mushrooms Quickly Emerging as Powerful Way

PR Newswire via COMTEX - Tue Nov 12, 08:45AM EST
Johns Hopkins Medicine and New York University aren't the only institutions uncovering the benefits of psilocybin mushrooms. According to a study featured in a 2016 issue of Science Direct, as highlighted by GOOD Magazine, psilocy(full story)
BOSQF: 0.2100 (+0.0004), WEED.TO: 20.29 (-0.67), CGC: 15.33 (-0.51)